Trading Ideas can sometimes be seen by looking at what a company insiders are doing. It is assumed they know something that we don't. So sometimes look thru this list for new ideas.NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from November 23 through November 27 include: Beneficial owner of BioLife Solutions ($BLFS) Casdin Partners purchased 1,600,000 shares of company stock at $22.50 per share for a total transaction value of $36,000,000 Director of Net 1 UEPS Technologies ($UEPS) Anthony Ball purchased 88,911 shares of company stock at $3.39 per share for a total transaction value of $301,408 Director of Merrimack Pharmaceuticals ($MACK) Eric Andersen purchased 69,088 shares of company stock at $3.65 per share for a total transaction value of $252,171 Beneficial owner of FTS International ($FTSI) THRC Holdings purchased 876,280 shares of company stock at $15.33 per share for a total transaction value of $13,435,475 Director of Coty ($COTY) Johannes Huth purchased 1,000,000 shares of company stock at $6.20 per share for a total transaction value of $6,199,000 NOTABLE INSIDER SALES: Significant insider sales in the prior week from November 23 through November 27 include: Director of Catalent ($CTLT) Peter Zippelius sold 5,392,280 shares of company stock at $99.26 per share for a total transaction value of $535,237,713 Beneficial owner of Container Store Group ($TCS) Green Equity sold 5,500,000 shares of company stock at $10.00 per share for a total transaction value of $55,000,000 Chairman of Carlyle Group ($CG) David Rubinstein sold 2,000,000 shares of company stock at $27.30 per share for a total transaction value of $54,600,000 Beneficial owner of Duck Creek Technologies ($DCT) Accenture sold 480,000 shares of company stock at $39.77 per share for a total transaction value of $19,089,600 COO of Palantir Technologies ($PLTR) Shyam Sankar sold 600,000 shares of company stock at $20.42 per share for a total transaction value of $12,250,620. NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Merrimack Pharmaceuticals are up 13% since Eric Andersen purchased 69,088 shares, while shares of Catalent are down over 6% since director Peter Zippelius sold 5.39M shares. Disclosure: I may trade in the ticker symbols mentioned, both long or short. My articles represent my personal opinion and analysis and should not be taken as investment advice. Readers should do their own research before making decisions to buy or sell securities. Trading and investing include risks, including loss of principal. If you liked this article, please click the LIKE (thumbs up) button. Feel free to leave any comments, question, or opinions. (Sign-up if you haven't already done so). Follow us/bookmark us and check back occasionally for additional articles or comments on our page... Wild Tiger Trading - start/main page. .Are you interested in trading stocks to supplement your income or make a living? Maybe become a professional trader? Many traders have the skills and nerves to trade, but not the upfront capital. Well now that problem is solved!Try2BeFunded has expanded its trading program! If you're a novice or experienced trader, you can earn access to a trading account with up to $100,000! To learn more about how to qualify, click HERE and give it a shot! You have nothing to lose it is free to try. Trade Try2BeFunded today! .